Supplemental material
Expert Review of Pharmacoeconomics & Outcomes Research
Volume 24, 2024 - Issue 5
Original Research
Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control
, , 
, , , & show all
María Laura Rosalesa Videnza Consultores, Videnza, Lima, Perúhttps://orcid.org/0000-0002-9486-2650View further author information
https://orcid.org/0000-0002-9486-2650View further author information, , , & show all